These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34545858)

  • 1. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.
    Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH
    Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps.
    Lucas E; Niu S; Aguilar M; Molberg K; Carrick K; Rivera-Colon G; Gwin K; Wang Y; Zheng W; Castrillon DH; Chen H
    Am J Surg Pathol; 2023 Sep; 47(9):1019-1026. PubMed ID: 37314146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
    Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
    Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer.
    Liu N; Lin W; Wang Y; Yao Z; Rivera-Colon G; Li Y; Carrick KS; Chen H; Lucas E; Zheng W
    Int J Gynecol Pathol; 2024 Sep; 43(5):494-505. PubMed ID: 38293998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome.
    Wyvekens N; Mutter GL; Nucci MR; Kolin DL; Parra-Herran C
    Histopathology; 2024 Oct; 85(4):579-589. PubMed ID: 38785042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
    Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
    Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems.
    Joiner AK; Quick CM; Jeffus SK
    Int J Gynecol Pathol; 2015 Jan; 34(1):40-6. PubMed ID: 25473752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
    Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
    Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers.
    Niu S; Lucas E; Molberg K; Strickland A; Wang Y; Carrick K; Rivera-Colon G; Gwin K; SoRelle JA; Castrillon DH; Zheng W; Chen H
    Am J Surg Pathol; 2022 Oct; 46(10):1447-1455. PubMed ID: 35834400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
    Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.
    Monte NM; Webster KA; Neuberg D; Dressler GR; Mutter GL
    Cancer Res; 2010 Aug; 70(15):6225-32. PubMed ID: 20631067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic diagnosis of endometrial precancers: Updates and future directions.
    Chen H; Strickland AL; Castrillon DH
    Semin Diagn Pathol; 2022 May; 39(3):137-147. PubMed ID: 34920905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
    APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
    Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
    Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Biomarker Expression Patterns in the Diagnosis of Residual and Recurrent Endometrial Precancers After Progestin Treatment: A Longitudinal Study.
    Chen H; Lucas E; Strickland AL; Carrick K; Gwin K; Castrillon DH; Rivera-Colon G; Niu S; Molberg KH; Zheng W
    Am J Surg Pathol; 2020 Oct; 44(10):1429-1439. PubMed ID: 32931681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions.
    Aguilar M; Chen H; Sahoo SS; Zheng W; Grubman J; SoRelle JA; Lucas E; Castrillon DH
    Am J Surg Pathol; 2023 May; 47(5):618-629. PubMed ID: 36939046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.
    Trabzonlu L; Muezzinoglu B; Corakci A
    Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.